SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Chronic relapsing ascending myelopathy: a treatable progressive neurological syndrome following traumatic spinal cord injury.

Visagan, R; Bandi, S; Robinson, L; Gadhok, A; Saadoun, S; Papadopoulos, MC (2022) Chronic relapsing ascending myelopathy: a treatable progressive neurological syndrome following traumatic spinal cord injury. Br J Neurosurg, 36 (6). pp. 792-795. ISSN 1360-046X https://doi.org/10.1080/02688697.2022.2102146
SGUL Authors: Papadopoulos, Marios Saadoun, Samira Visagan, Ravindran

[img] Microsoft Word (.docx) Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (80kB)

Abstract

BACKGROUND: We describe a novel progressive neurological syndrome complicating traumatic spinal cord injury (TSCI). Based on clinical and radiological features, we propose the term 'Chronic Relapsing Ascending Myelopathy' (CRAM). We distinguish between the previously described sub-acute progressive ascending myelopathy (SPAM) and post-traumatic syringomyelia (PTS), which may lie on a spectrum with CRAM. CASE REPORT: A 60-year-old man sustained a T4 ASIA-A complete TSCI. Four months post-injury, he developed a rapidly progressive ascending sensory level to C4. Clinical and radiological evaluation revealed ascending myelopathy with progressive T2 hyper-intense cord signal change. He underwent cord detethering and expansion duroplasty. Following an initial dramatic resolution of symptoms, the patient sustained two relapses, each 1-month post-discharge characterised by recurrence of disabling ascending sensory changes, each correlating with the radiological recurrence of cord signal change. Symptoms and radiological signal change permanently resolved with more extensive detethering and expansion duroplasty. There is radiological and clinical resolution at 1-year follow-up. CONCLUSION: Acute neurological deterioration post-TSCI may be due to SPAM or may occur after years due to PTS. We propose CRAM as a previously unrecognised phenomenon. The radiological characteristics overlap with SPAM. However, CRAM presents later and, clinically, behaves like PTS, but without cord cystic change. Cord detethering with expansion duroplasty are an effective treatment.

Item Type: Article
Additional Information: This is an Accepted Manuscript of an article published by Taylor & Francis in British Journal of Neurosurgery on 22/7/22, available at: https://doi.org/10.1080/02688697.2022.2102146
Keywords: Duroplasty, SPAM, spinal cord injury, sub-acute progressive ascending myelopathy, syringomyelia, Duroplasty, spinal cord injury, sub-acute progressive ascending myelopathy, SPAM, syringomyelia, 1103 Clinical Sciences, 1109 Neurosciences, Neurology & Neurosurgery
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Br J Neurosurg
ISSN: 1360-046X
Language: eng
Dates:
DateEvent
22 July 2022Published
11 July 2022Accepted
Publisher License: Publisher's own licence
PubMed ID: 35867035
Web of Science ID: WOS:000828945300001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114726
Publisher's version: https://doi.org/10.1080/02688697.2022.2102146

Actions (login required)

Edit Item Edit Item